Navigation Links
Physicians Hail VNUS Device for Closing Diseased Perforating Veins
Date:11/1/2007

ClosureRFS Stylet 'Ideal' for Treating Condition Affecting Four Million

Americans

SAN JOSE, Calif., Nov. 1 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, today announced the widespread success and rapid market growth of the VNUS ClosureRFS(TM) Stylet, an endovenous radiofrequency (RF) ablation catheter currently employed by more than 500 physicians to treat a specific varicose vein-related condition in the lower leg. The ClosureRFS Stylet is the only endovascular ablation device specifically cleared by the FDA for the treatment of incompetent perforating veins or IPVs, which can produce calf and ankle swelling and skin ulcerations in about four million Americans. Over 15,000 minimally invasive ClosureRFS procedures have been performed worldwide to heat and close diseased perforators.

"I have performed over 700 procedures with the ClosureRFS Stylet, and I consider it a giant step forward in our treatment of severe venous insufficiency," said Dr. Charles J. Rodman, MD., of Beaumont, Texas. "Our patients are primarily those with advanced venous disease, and they almost always present with large, incompetent perforating veins that unquestionably must be addressed in the course of treatment. The RFS Stylet is simple to use and small enough to handle with precision, and among physicians like myself treating this patient population, I believe there's uniform agreement that it's the best device available."

"ClosureRFS is absolutely the best way of closing perforators, with none of the drawbacks of other techniques we have researched," said Dr. Mark Whiteley, vascular surgeon and director of The Whiteley Clinic in Surrey, England. "The beauty of the RFS Stylet is that the ultrasound lets you know exactly where you are at all times during the procedure, so it reduces or eliminates the risk of complications, and you're certain of getting successful ablation of the vein exactly at the point you want it. Perforator incompetence has proven to be a common cause of varicose vein recurrence, even in patients whose truncal reflux disease has been successfully treated, so we know that where the condition exists, it must be treated -- and ClosureRFS is clearly the device of choice."

"In order to provide total vein care for venous insufficiency, I think it's vital to address perforating veins as well as the saphenous vein, because almost all of the leg ulcers and post-treatment recurrences we see are associated with diseased perforators," said Thomas Pester, MD., of El Paso, Texas. "The ClosureRFS Stylet is an ideal device for dealing with this issue -- it's very easy to use, the results are quite good and the patients are comfortable with it. I would recommend it to every physician treating patients with venous reflux disease."

ClosureRFS can be performed either as a primary outpatient procedure or as an adjunct to saphenous vein ablation procedures. VNUS has launched an improved version of the ClosureRFS Stylet, which now includes an integrated cable and a new streamlined hub designed for easier use and better ergonomics. For physicians seeking to treat the whole spectrum of venous pathology in managing patients with venous disease, the improved ClosureRFS Stylet is the only endovascular ablation device specifically cleared by the FDA for the treatment of incompetent perforator veins.

"The ClosureRFS Stylet has proven itself as a vital tool for physicians treating the perforator incompetence often seen in patients with advanced venous disease, and we're pleased with how quickly and enthusiastically it has been adopted by the medical community," said Brian E. Farley, President and CEO of VNUS. "This latest version of the RFS Stylet represents a major step forward, particularly in ease of use for physicians, and it addresses a rapidly growing market for the treatment of this form of venous insufficiency."

ABOUT VNUS MEDICAL TECHNOLOGIES, INC.

Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies (Nasdaq: VNUS) is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that causes the varicose veins afflicting 25 million Americans. The pioneering company in the field, VNUS now offers the ClosureFAST system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. VNUS devices have been used in more than 250,000 procedures worldwide. For more information, please visit http://www.vnus.com.


'/>"/>
SOURCE VNUS Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Startling Expose – Physicians Often Have No Regular Source Of Health Car
2. IMA to create database on physicians
3. "Make AIDS Therapy affordable" - Physicians demand
4. Physicians Consider Self-Prescribing Ethical
5. Guide for physicians launched to help them identify alcohol disorders
6. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
7. Physicians Need To Treat Patients With Respect For Treatment To Be Effective
8. Resident Physicians Need More Preparations To Treat Patients From Different Cultures
9. Physicians To Discuss Ways To Save Premature Babies From RSV
10. Physicians should encourage US women to breastfeed
11. Conflict over Productivity Commission report on physicians referral
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)...   Divoti USA will engrave and process ... of the latest FDA requirements, which stipulates new criteria regarding medical ... need of Medical ID jewelry such as Medical ID Bracelets, can ... in terms of the new FDA requirements . ... Divoti offers this dark mark fiber laser ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
Breaking Medicine Technology: